Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical Science [Banach M, Rizzo M, Toth PP, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015; 11(1): 1–23]

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550

ESC/EAS Guidelines for the management of dyslipidaemias

Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378

Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials

Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

Authors Task Force Members, Kristensen, S. D., Knuuti, J., Saraste, A., Anker, S. D., Bøtker, H. E., Hert, S. D., Ford, I., González‐Juanatey, J. R., Görenek, B., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu282 · Cited by 1,698

Statin-associated myopathy

Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Stroes, E. S., Thompson, P. D., Corsini, A., Vladutiu, G. D., Raal, F. J., Ray, K. K., Roden, M., Stein, E., Tokgözoğlu, L., Nordestgaard, B. G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv043 · Cited by 1,443

Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy: A Meta-analysis

Preiss, D. (2011) · JAMA · doi:10.1001/jama.2011.860 · Cited by 1,390

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study

Bruckert, E., Hayem, G., Dejager, S., Yau, C., & Bégaud, B. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-5686-z · Cited by 1,226

Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Values

MOFRAD, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,199

Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause Mortality

Weiner, D. E., Tighiouart, H., Amin, M. G., Stark, P. C., MacLeod, B., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000123691.46138.e2 · Cited by 1,172

Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association

Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

Graham, D. J. (2004) · JAMA · doi:10.1001/jama.292.21.2585 · Cited by 875

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863

The safety of statins in clinical practice

Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

Ridker, P. M., Pradhan, A., MacFadyen, J. G., Libby, P., & Glynn, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61190-8 · Cited by 816

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

McCarey, D. W., McInnes, I. B., Madhok, R., Hampson, R., Scherbakova, O., Ford, I., Capell, H. A., & Sattar, N. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16449-0 · Cited by 814

Statin Safety: A Systematic Review

Law, M., & Rudnicka, A. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.010 · Cited by 808

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

Authors Task Force Members, Poldermans, D., Bax, J. J., Boersma, E. H., Hert, S. G. D., Eeckhout, E., Fowkes, G. R., Görenek, B., Hennerici, M. G., Iung, B., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp337 · Cited by 739

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

Athyros, V. G., Tziomalos, K., Gossios, T. D., Griva, T., Anagnostis, P., Kargiotis, K., Pagourelias, E. D., Theocharidou, E., Karagiannis, A., & Mikhailidis, D. P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61272-x · Cited by 685

Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism

Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677

Genetic Polymorphisms in the 5′-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P450IIE1 Gene1

Hayashi, S., Watanabe, J. A., & Kawajiri, K. (1991) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123619 · Cited by 676

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

HPS2-THRIVE Collaborative Group, Haynes, R., Jiang, L., Hopewell, J. C., Li, J., Chen, F., Parish, S., Landray, M. J., Collins, R., Armitage, J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht055 · Cited by 676

A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease

Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Hepatology · doi:10.1002/hep.23623 · Cited by 568

Statin-associated myopathy with normal creatine kinase levels

Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00009 · Cited by 565

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group (2010) · The Lancet · doi:10.1016/s0140-6736(10)60310-8 · Cited by 558

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

Stroes, E., Colquhoun, D., Sullivan, D., Civeira, F., Rosenson, R. S., Watts, G. F., Bruckert, E., Cho, L., Dent, R., Knusel, B., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.019 · Cited by 526

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

Hippisley‐Cox, J., & Coupland, C. A. C. (2010) · BMJ · doi:10.1136/bmj.c2197 · Cited by 511

Effect of statins on skeletal muscle function

Parker, B. A., Capizzi, J. A., Grimaldi, A. S., Clarkson, P. M., Cole, S. M., Keadle, J., Chipkin, S., Pescatello, L. S., Simpson, K., White, C. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.136101 · Cited by 500

An assessment by the statin muscle safety task force: 2014 update

Rosenson, R. S., Baker, S. K., Jacobson, T. A., Kopecky, S. L., & Parker, B. A. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.03.004 · Cited by 485

Lipid-Lowering Therapy and In-Hospital Mortality Following Major Noncardiac Surgery

Lindenauer, P. K. (2004) · JAMA · doi:10.1001/jama.291.17.2092 · Cited by 467

Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis

Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sánchez, W. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.005 · Cited by 458

Narrative review: statin-related myopathy

Joy, T. R., & Hegele, R. A. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00009 · Cited by 453

Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients: The GAUSS Randomized Trial

Sullivan, D., Olsson, A. G., Scott, R., Kim, J. B., Xue, A., Gebski, V., Wasserman, S. M., & Stein, E. A. (2012) · JAMA · doi:10.1001/jama.2012.25790 · Cited by 447

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

Rajpathak, S. N., Kumbhani, D. J., Crandall, J., Barzilai, N., Alderman, M., & Ridker, P. M. (2009) · Diabetes Care · doi:10.2337/dc09-0738 · Cited by 439

Risk of incident diabetes among patients treated with statins: population based study

Carter, A. A., Gomes, T., Camacho, X., Juurlink, D. N., Shah, B. R., & Mamdani, M. M. (2013) · BMJ · doi:10.1136/bmj.f2610 · Cited by 404

New ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

Kristensen, S. D., & Knuuti, J. M. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu285 · Cited by 384

Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation

Huh, J. Y., Mougios, V., Kabasakalis, A., Fatouros, I., Siopi, A., Douroudos, I. I., Filippaios, A., Panagiotou, G., Park, K. H., & Mantzoros, C. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1437 · Cited by 363

Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years

Novâk, L. P. (1972) · Journal of Gerontology · doi:10.1093/geronj/27.4.438 · Cited by 358

Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort

Kavousi, M., Leening, M. J. G., Nanchen, D., Greenland, P., Graham, I. M., Steyerberg, E. W., Ikram, M. A., Stricker, B. H. C., Albert Hofman, D., & Franco, O. H. (2014) · JAMA · doi:10.1001/jama.2014.2632 · Cited by 350

Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing

Bjornsson, E. S., Jacobsen, E. I., & Kalaitzakis, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.023 · Cited by 320

Statin-induced myopathy: a review and update

Abd, T. T., & Jacobson, T. A. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.540568 · Cited by 320

Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease

Shepherd, J., Kastelein, J. J. P., Bittner, V., Deedwania, P., Breazna, A., Dobson, S., Wilson, D. J., Zuckerman, A., & Wenger, N. K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.072 · Cited by 302

Identification of FBL2 As a Geranylgeranylated Cellular Protein Required for Hepatitis C Virus RNA Replication

Wang, C., Gale, M., Keller, B. C., Huang, H., Brown, M. S., Goldstein, J. L., & Ye, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.004 · Cited by 293

Improved Postoperative Outcomes Associated with Preoperative Statin Therapy

Hindler, K., Shaw, A., Samuels, J., Fulton, S., Collard, C. D., Riedel, B., & Warltier, D. C. (2006) · Anesthesiology · doi:10.1097/00000542-200612000-00027 · Cited by 288

Cellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease

Abrass, C. K. (2004) · American Journal of Nephrology · doi:10.1159/000075925 · Cited by 280

Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30 000 patients

Liakopoulos, O. J., Choi, Y., Haldenwang, P. L., Strauch, J., Wittwer, T., Dörge, H., Stamm, C., Wassmer, G., & Wahlers, T. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn198 · Cited by 279

An Assessment of Statin Safety by Hepatologists

Cohen, D. E., Anania, F. A., & Chalasani, N. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.014 · Cited by 269

Statin Safety: An Overview and Assessment of the Data—2005

Bays, H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.006 · Cited by 264

An Assessment of Statin Safety by Muscle Experts

Thompson, P. D., Clarkson, P. M., & Rosenson, R. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.013 · Cited by 263

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education

Wei, M. Y., Ito, M. K., Cohen, J. D., Brinton, E. A., & Jacobson, T. A. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.03.001 · Cited by 260

Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial

Foster, T., Budoff, M. J., Saab, S., Ahmadi, N., Gordon, C., & Guerci, A. D. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.299 · Cited by 260

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases

Dormuth, C. R., Hemmelgarn, B. R., Paterson, J. M., James, M. T., Teare, G. F., Raymond, C. B., Lafrance, J., Levy, A. R., Garg, A. X., Ernst, P., et al. (2013) · BMJ · doi:10.1136/bmj.f880 · Cited by 253

Clinical Perspectives of Statin-Induced Rhabdomyolysis

Antons, K., Williams, C. D., Baker, S. K., & Phillips, P. S. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.007 · Cited by 236

An assessment by the Statin Liver Safety Task Force: 2014 update

Bays, H. E., Cohen, D. E., Chalasani, N., & Harrison, S. A. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.02.011 · Cited by 235

Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline

Tonelli, M., Wanner, C., & for the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2453 · Cited by 226

Resistance and intolerance to statins

Reiner, Ž. (2014) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.05.009 · Cited by 225

Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems

Sinzinger, H. F., & O’Grady, J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02044.x · Cited by 223

Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study

Kokkinos, P. F., Faselis, C., Myers, J., Panagiotakos, D., & Doumas, M. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61426-3 · Cited by 217

The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials

Schooling, C. M., Yeung, S. L. A., Freeman, G., & Cowling, B. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-57 · Cited by 215

What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice

Finegold, J. A., Manisty, C. H., Goldacre, B., Barron, A. J., & Francis, D. P. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314525531 · Cited by 214

The liver and lovastatin

Tolman, K. G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02355-x · Cited by 213

Statin-Induced Muscle Necrosis in the Rat: Distribution, Development, and Fibre Selectivity

Westwood, F. R., Bigley, A. L., Randall, K., Marsden, A. M., & Scott, R. C. (2005) · Toxicologic Pathology · doi:10.1080/01926230590908213 · Cited by 212

The Impact of Postoperative Discontinuation or Continuation of Chronic Statin Therapy on Cardiac Outcome After Major Vascular Surgery

Manach, Y. L., Godet, G., Coriat, P., Martinon, C., Bertrand, M., Fléron, M. H., & Riou, B. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000263029.72643.10 · Cited by 211

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study

Athyros, V. G., Elisaf, M., Papageorgiou, A. A., Symeonidis, A. N., Pehlivanidis, A. N., Bouloukos, V. I., Milionis, H. J., & Mikhailidis, D. P. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.12.023 · Cited by 209

Hypothyroidism: an update

Gaitonde, D., Rowley, K. D., & Sweeney, L. (2012) · South African Family Practice · doi:10.1080/20786204.2012.10874256 · Cited by 209

Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study

Donnelly, L. A., Doney, A. S. F., Tavendale, R., Lang, C. C., Pearson, E. R., Colhoun, H. M., McCarthy, M. I., Hattersley, A. T., Morris, A. D., & Palmer, C. N. A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.255 · Cited by 204

Effects of Coenzyme Q10 on Statin-Induced Myopathy

Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., et al. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.08.021 · Cited by 198

The role of Toll-like receptors in renal diseases

Gluba-Brzózka, A., Banach, M., Hannam, S., Mikhailidis, D. P., Sakowicz, A., & Rysz, J. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.16 · Cited by 197

Aging and drug disposition: an update.

Schmucker, D. L. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06825-5 · Cited by 192

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

Visser, M. E., Wagener, G., Baker, B. F., Geary, R. S., Donovan, J. M., Beuers, U. H., Nederveen, A. J., Verheij, J., Trip, M. D., Basart, D. C. G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs023 · Cited by 191

New insights into mechanisms of statin-associated myotoxicity

Sirvent, P., Mercier, J. G., & Lacampagne, A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.010 · Cited by 190

Intolerance to Statins: Mechanisms and Management

Bitzur, R., Cohen, H., Kamari, Y., & Harats, D. (2013) · Diabetes Care · doi:10.2337/dcs13-2038 · Cited by 185

Lovastatin increases exercise-induced skeletal muscle injury

Thompson, P. D., Zmuda, J. M., Domalik, L. J., Zimet, R., Staggers, J. E., & Guyton, J. R. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90218-3 · Cited by 177

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update

Mancini, G. B. J., Tashakkor, A. Y., Baker, S., Bergeron, J., Fitchett, D., Frohlich, J., Genest, J., Gupta, M., Hegele, R. A., Ng, D. S., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.09.023 · Cited by 173

Analysis of vitamin D levels in patients with and without statin-associated myalgia — A systematic review and meta-analysis of 7 studies with 2420 patients

Michalska, M., Sahebkar, A., Mikhailidis, D. P., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Hovingh, G. K., Farnier, M., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.10.118 · Cited by 171

Toward “Pain-Free” Statin Prescribing: Clinical Algorithm for Diagnosis and Management of Myalgia

Jacobson, T. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.6.687 · Cited by 170

An assessment by the Statin Intolerance Panel: 2014 update

Guyton, J. R., Bays, H. E., Grundy, S. M., & Jacobson, T. A. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.03.002 · Cited by 165

Statin induced myopathy

Sathasivam, S., & Lecky, B. R. F. (2008) · BMJ · doi:10.1136/bmj.a2286 · Cited by 164

Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels

Tikkanen, M. J., Fayyad, R. S., Færgeman, O., OLSSON, A. G., Wun, C., Laskey, R. E., Kastelein, J. J. P., Holme, I., & Pedersen, T. R. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.024 · Cited by 160

Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial

Moriarty, P. M., Jacobson, T. A., Bruckert, E., Thompson, P. D., Guyton, J. R., Baccara-Dinet, M. T., & Gipe, D. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.09.007 · Cited by 154

Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review

Noël, B. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01838.x · Cited by 154

Serum cholesterol concentration and death from suicide in men: Paris prospective study I

Zureik, M., Courbon, D., & Ducimetière, P. (1996) · BMJ · doi:10.1136/bmj.313.7058.649 · Cited by 151

Fatty liver, insulin resistance, and dyslipidemia

Adiels, M., Taskinen, M., & Borén, J. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0011-4 · Cited by 147

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators*

Amarenco, P., Bogousslavsky, J., Callahan, A. S., III, Gold, L. B., Hennerici, M. G., Rudolph, A. E., Sillesen, H. H., Simunovic, L., Szarek, M. J., Welch, K. M. A., et al. (2006) · Cited by 145

Different Time Trends of Caloric and Fat Intake Between Statin Users and Nonusers Among US Adults

Sugiyama, T., Tsugawa, Y., Tseng, C., Kobayashi, Y., & Shapiro, M. F. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.1927 · Cited by 144

Alcohol Screening Scores and Medication Nonadherence

Bryson, C. L., Au, D. H., Sun, H., Williams, E. C., Kivlahan, D. R., & Bradley, K. A. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-11-200812020-00004 · Cited by 138

Changes in Ubiquitin Proteasome Pathway Gene Expression in Skeletal Muscle With Exercise and Statins

Urso, M. L., Clarkson, P. M., Hittel, D. S., Hoffman, E. P., & Thompson, P. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000190608.28704.71 · Cited by 128

Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD

Lonardo, A., Sookoian, S. C., Chonchol, M., Loria, P., & Targher, G. (2012) · Current Pharmaceutical Design · doi:10.2174/1381612811319290003 · Cited by 125

Statin induced myopathy.

Frank, R. E. (2009) · PubMed · Cited by 120

Statin Use Associates with a Lower Incidence of Acute Kidney Injury after Major Elective Surgery

Molnar, A. O., Coca, S. G., Devereaux, P. J., Jain, A. K., Kitchlu, A., Luo, J. J., Parikh, C. R., Paterson, J. M., Siddiqui, N., Wald, R., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050442 · Cited by 119

Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes

Kwak, H.-B., Thalacker-Mercer, A., Anderson, E. J., Lin, C.-T., Kane, D. A., Lee, N.-S., Cortright, R. N., Bamman, M. M., & Neufer, P. D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.449 · Cited by 114

Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development #

Delang, L., Paeshuyse, J., Vliegen, I., Leyssen, P., Obeid, S., Durantel, D., Zoulim, F., Beeck, A. O. D., & Neyts, J. H. (2009) · Hepatology · doi:10.1002/hep.22916 · Cited by 111

Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis.

Rysz, J., Banach, M., Ciałkowska-Rysz, A. D., Stolarek, R. A., Barylski, M., Dróżdż, J., & Okoński, P. (2006) · PubMed · Cited by 109

Statin myotoxicity: a review of genetic susceptibility factors

Needham, M., & Mastaglia, F. L. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.09.011 · Cited by 108

Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study

Monda, K. L., Ballantyne, C. M., & North, K. E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900029-jlr200 · Cited by 107

Efficacy and Safety of Statin Monotherapy in Older Adults: A Meta-Analysis

Roberts, C. G. P., Güallar, E., & Rodríguez, A. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.8.879 · Cited by 107

Cerivastatin, genetic variants, and the risk of rhabdomyolysis

Marciante, K. D., Durda, J. P., Heckbert, S. R., Lumley, T., Rice, K. M., McKnight, B., Totah, R. A., Tamraz, B., Kroetz, D. L., Fukushima, H., et al. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328343dd7d · Cited by 106

Statin use and musculoskeletal pain among adults with and without arthritis

Buettner, C., Rippberger, M. J., Smith, J. K., Leveille, S. G., Davis, R. B., & Mittleman, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.08.007 · Cited by 102

Association of Statin Use With Cataracts

Leuschen, J., Mortensen, E. M., Frei, C. R., Mansi, E. A., Panday, V. A., & Mansi, I. A. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.4575 · Cited by 102

Statin‐associated myopathy and its exacerbation with exercise

Meador, B. M., & Huey, K. A. (2010) · Muscle & Nerve · doi:10.1002/mus.21817 · Cited by 99

Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants

Barylski, M., Nikfar, S., Mikhailidis, D. P., Toth, P. P., Salari, P., Ray, K. K., Pencina, M. J., Rizzo, M., Rysz, J., Abdollahi, M., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.03.007 · Cited by 98

Effect of Statins on Creatine Kinase Levels Before and After a Marathon Run

Parker, B. A., Augeri, A. L., Capizzi, J. A., Ballard, K. D., Troyanos, C., Baggish, A. L., d’Hemecourt, P. A., & Thompson, P. D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.08.045 · Cited by 98

Statins and Interstitial Lung Disease

Fernández, A. B., Karas, R. H., Alsheikh-Ali, A. A. A., & Thompson, P. D. (2008) · CHEST Journal · doi:10.1378/chest.08-0943 · Cited by 97

Lipids, blood pressure and kidney update 2014

Banach, M., Aronow, W. S., Șerban, M.-C., Sahabkar, A., Rysz, J., Voroneanu, L. E., & Covic, A. C. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.009 · Cited by 92

Severe irritability associated with statin cholesterol-lowering drugs

Golomb, B. A., Kane, T., & Dimsdale, J. E. (2004) · QJM · doi:10.1093/qjmed/hch035 · Cited by 91

Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins

Sirvent, P., Fabre, O., Bordenave, S., Hillaire-Buys, D., Raynaud De Mauverger, E., Lacampagne, A., & Mercier, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.01.008 · Cited by 90

FDA drug safety communications: a narrative review and clinical considerations for older adults

Marcum, Z. A., Vande Griend, J. P., & Linnebur, S. A. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.05.002 · Cited by 85

The Effect of Statins on Erectile Dysfunction: A Meta‐Analysis of Randomized Trials

Kostis, J. B., & Dobrzynski, J. M. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12521 · Cited by 82

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

Athyros, V. G., Γιουλεμέ, Ό., Ganotakis, E. S., Elisaf, M., Τζιόμαλος, Κ., Vassiliadis, T. G., Liberopoulos, E. N., Theocharidou, E., Karagiannis, A. I., & Mikhailidis, D. P. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.25554 · Cited by 82

A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?

Nikolić, D., Banach, M., Nikfar, S., Salari, P., Mikhailidis, D. P., Toth, P. P., Abdollahi, M. R., Ray, K. K., Pencina, M. J., Małyszko, J., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.060 · Cited by 80

Statins and primary liver cancer

Pradelli, D., Soranna, D., Scotti, L., Zambon, A., Catapano, A. L., Mancia, G., Vecchia, C. L., & Corrao, G. (2012) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328358761a · Cited by 80

Lipid, blood pressure and kidney update 2013

Banach, M., Serban, C., Aronow, W. S., Rysz, J., Dragan, S. R., Lerma, E. V., Apetrii, M., & Covic, A. C. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0657-6 · Cited by 78

Statin use and risk of hepatocellular carcinoma

Lai, S., Liao, K.-F., Lai, H., Muo, C., Sung, F.-C., & Chen, P. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9806-y · Cited by 75

Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance

Banach, M., Małodobra-Mazur, M., Gluba-Brzózka, A., Katsiki, N., Rysz, J., & Dobrzyń, A. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319270014 · Cited by 71

Time for new indications for statins?

Banach, M., Mikhailidis, D. P., Kjeldsen, S. E., & Rysz, J. (2009) · PubMed · Cited by 68

Statin therapy in the elderly: A review

Szadkowska, I., Stańczyk, A., Aronow, W. S., Kowalski, J., Pawlicki, L., Ahmed, A., & Banach, M. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2008.12.012 · Cited by 67

Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: A population‐based study

Vera, M. A. D., Choi, H. K., Abrahamowicz, M., Kopec, J. A., & Lacaille, D. V. (2012) · Arthritis Care & Research · doi:10.1002/acr.21643 · Cited by 67

High-dose Atorvastatin After Stroke or Transient Ischemic Attack

Amarenco, P., Bogousslavsky, J., & Callahan, A. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.10.008 · Cited by 62

State of the art papers Lipids, blood pressure, kidney – what was new in 2011?

Barylski, M., Małyszko, J., Rysz, J., Myśliwiec, M., & Banach, M. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.26620 · Cited by 62

Life Style-Related Diseases of the Digestive System: Cell Culture System for the Screening of Anti-Hepatitis C Virus (HCV) Reagents: Suppression of HCV Replication by Statins and Synergistic Action With Interferon

Ikeda, M., & Kato, N. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fm0070050 · Cited by 61

Can Statins Cause Chronic Low-Grade Myopathy?

Grundy, S. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00015 · Cited by 60

Contrasting Cholesterol Management Guidelines for Adults with CKD

Colantonio, L. D., Baber, U., Banach, M., Tanner, R. M., Warnock, D. G., Gutiérrez, O. M., Safford, M. M., Wanner, C., Howard, G., & Muntner, P. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040400 · Cited by 60

A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes

Marenzi, G., Cosentino, N., Werba, J. P., Tedesco, C. C., Veglia, F., & Bartorelli, A. L. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.046 · Cited by 59

Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment

Stojaković, T., Claudel, T., Putz‐Bankuti, C., Fauler, G., Scharnagl, H., Wagner, M., Sourij, H., Stauber, R. E., Winkler, K., März, W., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.052 · Cited by 59

Proprotein Convertase Subtilisin/Kexin 9 Inhibitors

Dragan, S. R., Șerban, M.-C., & Banach, M. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414539562 · Cited by 58

Rhabdomyolysis and Satin Therapy: Relevance to the Elderly

Sica, D. A., & Gehr, T. W. B. (2002) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2002.01422.x · Cited by 57

Use of statins is associated with an increased risk of rheumatoid arthritis

de Jong, H. J. I., Klungel, O. H., van Dijk, L., Vandebriel, R. J., Leufkens, H. G. M., van der Laan, J., Tervaert, J. W. C., & Loveren, H. V. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.155622 · Cited by 57

Lipids, blood pressure and kidney update 2015

Banach, M., Aronow, W. S., Șerban, M.-C., Rysz, J., Voroneanu, L. E., & Covic, A. C. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0169-0 · Cited by 57

How to use statins in patients with chronic liver disease.

Russo, M. W., & Jacobson, I. M. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.1.58 · Cited by 56

Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis

Cash, W. J., O’Neill, S., O’Donnell, M. E., McCance, D. R., Young, I. S., McEneny, J., McDougall, N., & Callender, M. E. (2013) · Liver International · doi:10.1111/liv.12191 · Cited by 56

Cold Tolerance in Hypothyroid Rabbits: Role of Skeletal Muscle Mitochondria and Sarcoplasmic Reticulum Ca2+ ATPase Isoform 1 Heat Production

Arruda, A. P., Ketzer, L. A., Nigro, M., Galina, A., Carvalho, D. P., & de Meis, L. (2008) · Endocrinology · doi:10.1210/en.2008-0564 · Cited by 55

The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg

Kearns, A. K., Bilbie, C., Clarkson, P. M., White, C. M., Sewright, K. A., O’Fallon, K. S., Gadarla, M., & Thompson, P. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.029 · Cited by 53

Generalized Eczematous Skin Rash Possibly due to HMG-CoA Reductase Inhibitors

Krasovec, M., Elsner, P. L., & Burg, G. (2009) · Dermatology · doi:10.1159/000247363 · Cited by 53

Statin-Associated Psychiatric Adverse Events

Tuccori, M., Lapi, F., Testi, A., Coli, D., Moretti, U., Vannacci, A., Motola, D., Salvo, F., Rivolta, A. L., Blandizzi, C., et al. (2008) · Drug Safety · doi:10.2165/0002018-200831120-00007 · Cited by 52

Systematic review and meta‐analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present

McClure, D. L., Valuck, R. J., Glanz, M., & Hokanson, J. E. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1341 · Cited by 52

Thrombotic thrombocytopenic purpura and simvastatin

McCarthy, L. J., Porcu, P., Fausel, C. A., Sweeney, C. J., & Danielson, C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70492-x · Cited by 51

Prevention of Atherosclerosis in Overweight/Obese Patients - In Need of Novel Multi-Targeted Approaches -

Lim, S. K., Després, J., & Koh, K. K. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-1240 · Cited by 48

Diplopia, Blepharoptosis, and Ophthalmoplegia and 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor Use

Fraunfelder, F. W., & Richards, A. B. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.08.006 · Cited by 47

Subclinical hypothyroidism and vascular risk: An update

Lioudaki, E., Mavroeidi, N., Mikhailidis, D. P., & Ganotakis, E. S. (2013) · HORMONES · doi:10.14310/horm.2002.1437 · Cited by 45

Nephroprotective and clinical potential of statins in dialyzed patients

Rysz, J., Aronow, W. S., Stolarek, R. S., Hannam, S., Mikhailidis, D. P., & Banach, M. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902882130 · Cited by 44

Pravastatin‐induced lichenoid drug eruption

Pua, V. S., Scolyer, R. A., & Barnetson, R. S. (2006) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2006.00225.x · Cited by 43

Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study

Athyros, V. G., Katsiki, N., Τζιόμαλος, Κ., Gossios, T. D., Theocharidou, E., Gkaliagkousi, E., Anagnostis, P. G., Pagourelias, E. D., Karagiannis, A. I., & Mikhailidis, D. P. (2013) · Archives of Medical Science · doi:10.5114/aoms.2013.35424 · Cited by 42

Liver tests are irrelevant when prescribing statins

Bader, T. F. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62142-3 · Cited by 42

Statin discontinuation: an underestimated risk?

Τζιόμαλος, Κ., Athyros, V. G., & Mikhailidis, D. P. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802469102 · Cited by 42

Management of statin intolerance

Raju, S. B., Varghese, K., & Madhu, K. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.122602 · Cited by 40

Toxic Epidermal Necrolysis From Atorvastatin

Pfeiffer, C., Kazenoff, S., & Rothberg, H. D. (1998) · JAMA · doi:10.1001/jama.279.20.1613-a · Cited by 39

Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?

Athyros, V. G., Τζιόμαλος, Κ., Daskalopoulos, G. N., Karagiannis, A. I., & Mikhailidis, D. P. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.561363 · Cited by 39

Screening Stress Myocardial Perfusion Imaging and Eligibility for Liver Transplantation

Bradley, S. M., Soine, L. A., Caldwell, J. H., & Goldberg, S. L. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.11.023 · Cited by 39

Yes! Statins can be given to liver patients

Bader, T. F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.016 · Cited by 38

Is decreased libido associated with the use of HMG‐CoA‐reductase inhibitors?

de Graaf, L., Brouwers, A. H., & Diemont, W. L. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02128.x · Cited by 38

Simvastatin‐induced thrombocytopenia

Groneberg, D. A., Barkhuizen, A., & Jeha, T. (2001) · American Journal of Hematology · doi:10.1002/ajh.1136 · Cited by 36

Statins in Primary Biliary Cirrhosis: Are They Safe?

Rajab, M. A., & Kaplan, M. M. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0988-9 · Cited by 35

Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle

Glueck, C. J., Abuchaibe, C., & Wang, P. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.07.007 · Cited by 34

Role and significance of statins in the treatment of hypertensive patients

Stȩpień, M., Banach, M., Mikhailidis, D. P., Gluba-Brzózka, A., Kjeldsen, S. E., & Rysz, J. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903098081 · Cited by 34

Perioperative pleiotropic statin effects in general surgery

Iannuzzi, J. C., Rickles, A. S., Kelly, K. N., Rusheen, A. E., Dolan, J. G., Noyes, K., Monson, J. R. T., & Fleming, F. J. (2013) · Surgery · doi:10.1016/j.surg.2013.11.008 · Cited by 34

Asymptomatic hypothyroidism and statin-induced myopathy.

Bar, S. L., Holmes, D. T., & Frohlich, J. J. (2007) · Europe PMC (PubMed Central) · Cited by 34

Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism

Ali, N., Allam, H., Bader, T. F., May, R. J., Basalingappa, K. M., Berry, W. L., Chandrakesan, P., Qu, D., Weygant, N., Bronze, M. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080304 · Cited by 33

Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case Approach

de Jong, H. J. I., Saldi, S. R. F., Klungel, O. H., Vandebriel, R. J., Souverein, P. C., Meyboom, R. H. B., Passier, A., Loveren, H. V., & Tervaert, J. W. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041289 · Cited by 32

Statin use and risk of diabetes mellitus in postmenopausal women

Katsiki, N., & Banach, M. (2012) · Clinical Lipidology · doi:10.2217/clp.12.28 · Cited by 32

Dermographism: an adverse effect of atorvastatin.

ADCOCK, B. B., Hornsby, L. B., & Jenkins, K. (2001) · PubMed · Cited by 31

Simvastatin induced rhabdomyolysis and an important clinical link with hypothyroidism

Kiernan, T. J., Rochford, M., & McDermott, J. H. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.233 · Cited by 30

Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database

Moulis, G., Béné, J., Sommet, A., Sailler, L., Lapeyre‐Mestre, M., & Montastruc, J. (2012) · Lupus · doi:10.1177/0961203312436861 · Cited by 30

Statin use increases the risk of depressive disorder in stroke patients: A population-based study

Kang, J., Kao, L., Lin, H., Tsai, M.-C., & Chung, S. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.11.013 · Cited by 30

Statins and New-Onset Diabetes

Barylski, M., Nikolić, D., Banach, M., Toth, P. P., Montalto, G., & Rizzo, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660678 · Cited by 30

The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review

Mihos, C. G., Artola, R. T., & Santana, O. (2011) · Rheumatology International · doi:10.1007/s00296-011-2008-6 · Cited by 29

Statins in patients with chronic kidney disease: why, who and when?

Gluba-Brzózka, A., Rysz, J., & Banach, M. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.512419 · Cited by 29

Nightmares and Sleep Disturbances with Simvastatin and Metoprolol

Boriani, G., Biffi, M., Strocchi, E., & Branzi, A. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a079 · Cited by 29

Tresch and Aronow’s Cardiovascular Disease in the Elderly

(2019) · CRC Press eBooks · doi:10.1201/9781315151311 · Cited by 29

Lipid-Lowering Medication Use and Aggression Scores in Women: A Report from the NHLBI-Sponsored WISE Study

Olson, M. B., Kelsey, S. F., Matthews, K. A., Merz, C. N. B., Eteiba, W., McGorray, S. P., Cornell, C. E., Vido, D. A., & Muldoon, M. F. (2008) · Journal of Women s Health · doi:10.1089/jwh.2007.0379 · Cited by 28

Thrombotic Thrombocytopenic Purpura: Yesterday, Today, Tomorrow

McCarthy, L. J., Dlott, J. S., Orazi, A., Waxman, D. A., Miraglia, C. C., & Danielson, C. (2004) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1526-0968.2003.00113.x · Cited by 27

Updates on Cytochrome P450-Mediated Cardiovascular Drug Interactions

Cheng, J. W. M., Frishman, W. H., & Aronow, W. S. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31813e63be · Cited by 26

Statins, Exercise, and Exercise Training

Thompson, P. D., & Parker, B. A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.030 · Cited by 23

Simvastatın improves endothelial function in patents with subclinical hypothyroidism

Duman, D., Şahin, S., Esertas, K., & Demirtunç, R. (2007) · Heart and Vessels · doi:10.1007/s00380-006-0950-0 · Cited by 23

Alopecia associated with atorvastatin

Segal, A. S. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01135-x · Cited by 22

Cardiovascular drug therapy in the elderly.

Aronow, W. S., Frishman, W. H., & Cheng-Lai, A. (2000) · PubMed · Cited by 22

Are statins ‘IDEAL’ for non-alcoholic fatty liver disease?

Athyros, V. G., Katsiki, N., Karagiannis, A. I., & Mikhailidis, D. P. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.855192 · Cited by 21

Chronic urticaria to atorvastatin

Anliker, M. D., & Wüthrich, B. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.1n3628.x · Cited by 21

Atorvastatin-Induced Diaphragmatic Muscle Impairment

Sulem, P., Bagheri, H., Faixo, Y., & Montastruc, J. L. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.10366 · Cited by 21

Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD

Lonardo, A., Sookoian, S. C., Chonchol, M., Loria, P., & Targher, G. (2012) · Current Pharmaceutical Design · doi:10.2174/13816128130301 · Cited by 21

Jaundice Due to Suspected Statin Hepatotoxicity: A Case Series

Bergmann, O. M., Kristjánsson, G., Jonasson, J. G., & Bjornsson, E. S. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1950-1 · Cited by 19

Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature

Roberto, G., Biagi, C., Montanaro, N., Koci, A., Moretti, U., & Motola, D. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1218-5 · Cited by 19

Treatment of hypercholesterolemia in patients with primary biliary cirrhosis might be more beneficial than indicated

Balmer, M. L. (2008) · Swiss Medical Weekly · doi:10.4414/smw.2008.12311 · Cited by 19

Moderate Alcohol Consumption and Safety of Lovastatin and Warfarin Among Men: The Post-Coronary Artery Bypass Graft Trial

Mukamal, K. J., Smith, C. C., Karlamangla, A. S., & Moore, A. A. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.038 · Cited by 18

Two Cases of Statin-Induced Myopathy Caused By Induced Hypothyroidism

Lando, H. M., & Burman, K. D. (2008) · Endocrine Practice · doi:10.4158/ep.14.6.726 · Cited by 18

Effects of Alcohol and Fluvastatin on Lipid Metabolism and Hepatic Function

Smit, J. W. A., Wijnne, H. J. A., Schobben, F., Sitsen, A., de Bruin, T. W. A., & Erkelens, D. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-9-199505010-00006 · Cited by 17

Patient attitudes towards a new role for pharmacists: continued dispensing

Abukres, S. H., Hoti, K., & Hughes, J. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s66719 · Cited by 16

Successful reintroduction of statin therapy after myositis: was there another cause?

Rando, L. P., Cording, S. A., & Newnham, H. H. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06030.x · Cited by 16

The tolerability and efficacy of low-dose simvastatin in statin-intolerant patients

Degreef, L. E., Opdam, F. L., Teepe‐Twiss, I. M., Jukema, J. W., Guchelaar, H., & Tamsma, J. T. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.03.015 · Cited by 12

Statin therapy and new-onset diabetes: an attempt at recommendations

Banach, M., & Mikhailidis, D. P. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.13.16 · Cited by 12

Adolescent with Rhabdomyolysis due to Undiagnosed Hypothyroidism

Farias‐Moeller, R., Zecavati, N., Sherafat‐Kazemzadeh, R., Aleinikoff, S., & Rennert, W. P. (2011) · Case Reports in Pediatrics · doi:10.1155/2011/670673 · Cited by 10

Statin adverse effects: sorting out the evidence.

Mlodinow, S. G., Onysko, M. K., Vandiver, J. W., Hunter, M. L., & Mahvan, T. D. (2014) · PubMed · Cited by 10

Editorial Statin treatment in the elderly: how much do we know?

Rizzo, M., Nikolić, D., Banach, M., & Montalto, G. (2013) · Archives of Medical Science · doi:10.5114/aoms.2013.37275 · Cited by 9

Smoking and non-alcoholic steatohepatitis (NASH): The GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial

Katsiki, N., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.013 · Cited by 6

Disorders of Lipid Metabolism

Thomas, J. E., & Foody, J. M. (2008) · Fundamental and clinical cardiology · doi:10.3109/9781420061710.006 · Cited by 5

Statins Should Be Used with Greater Caution in Patients Undergoing Thyroid Hormone Withdrawal for Radioactive Iodine Treatment

Al‐Salameh, A., Bihan, H., Keller, I., Reach, G., Dhôte, R., & Cohen, R. (2011) · Thyroid · doi:10.1089/thy.2010.0317 · Cited by 2

Statin-Associated Side Effects

Thompson, P. D., Panza, G. A., Zaleski, A. L., & Taylor, B. A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.071 · Cited by 776

Safety and efficacy of statin therapy

Adhyaru, B. B., & Jacobson, T. A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0098-5 · Cited by 424

Gender differences in the effects of cardiovascular drugs

Tamargo, J. L., Rosano, G. M. C., Walther, T., Duarte, J., Niessner, A., Kaski, J., Ceconi, C., Drexel, H., Kjeldsen, K. P., Savarese, G., et al. (2016) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvw042 · Cited by 325

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O. S., Djuric, D. M., Владиславович, Е. М., Fras, Z., Katsiki, N., Langlois, M. R., Latkovskis, G., et al. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux047 · Cited by 303

The Role of Nutraceuticals in Statin Intolerant Patients

Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.040 · Cited by 272

Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al‐Rasadi, K., Aronow, W. S., Athyros, V. G., Djuric, D. M., Владиславович, Е. М., et al. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.49807 · Cited by 386

Statin intolerance – a question of definition

Algharably, E. A. E., Filler, I., Rosenfeld, S., Grabowski, K., & Kreutz, R. H. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1238898 · Cited by 19

Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects

Li, J., Liu, H.-H., Wu, N., Yeo, K. K., Tan, K. C. B., Ako, J., Krittayaphong, R., Tan, R., Aylward, P. E., Baek, S. H., et al. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1802426 · Cited by 19

2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance

Chien, S.-C., Chen, P.-S., Huang, Y., Tang, S., Li, Y.-H., & Yeh, H. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.11.017 · Cited by 26

P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel

Penson, P. E., Toth, P. P., Mikhailidis, D. P., Владиславович, Е. М., Fras, Z., Mitchenko, O., Pella, D., Sahebkar, A., Rysz, J., Reiner, Ž., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz747.0310 · Cited by 11